Natixis Advisors
MPT

Natixis Advisors’s Medical Properties Trust MPT Stock Holding History

Natixis Advisors’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$493K Sell
106,516
-65,243
-38% -$340K ﹤0.01% 1557
2025
Q4 		$859K Buy
171,759
+70,743
+70% +$368K ﹤0.01% 1307
2025
Q3 		$512K Buy
101,016
+9,959
+11% +$43.9K ﹤0.01% 1485
2025
Q2 		$392K Buy
91,057
+3,978
+5% +$19.7K ﹤0.01% 1510
2025
Q1 		$525K Buy
+87,079
New +$440K ﹤0.01% 1444
2024
Q4 		– Sell
-80,028
Closed -$468K – 1650
2024
Q3 		$468K Buy
80,028
+4,231
+6% +$20.9K ﹤0.01% 1468
2024
Q2 		$327K Buy
75,797
+20,999
+38% +$101K ﹤0.01% 1508
2024
Q1 		$258K Buy
+54,798
New +$210K ﹤0.01% 1490
2023
Q3 		– Sell
-41,272
Closed -$382K – 1515
2023
Q2 		$382K Buy
41,272
+13,536
+49% +$114K ﹤0.01% 1394
2023
Q1 		$228K Buy
27,736
+3,038
+12% +$33.5K ﹤0.01% 1444
2022
Q4 		$275K Sell
24,698
-33,867
-58% -$394K ﹤0.01% 1412
2022
Q3 		$695K Sell
58,565
-1,373
-2% -$20.8K ﹤0.01% 1196
2022
Q2 		$915K Sell
59,938
-71,938
-55% -$1.29M ﹤0.01% 1145
2022
Q1 		$2.79M Buy
131,876
+67,098
+104% +$1.45M 0.01% 866
2021
Q4 		$1.53M Buy
64,778
+11,510
+22% +$247K 0.01% 1029
2021
Q3 		$1.07M Buy
53,268
+12,883
+32% +$264K ﹤0.01% 1076
2021
Q2 		$812K Sell
40,385
-4,611
-10% -$98.6K ﹤0.01% 1135
2021
Q1 		$957K Buy
44,996
+6,457
+17% +$139K 0.01% 1071
2020
Q4 		$840K Buy
38,539
+4,514
+13% +$88K ﹤0.01% 1046
2020
Q3 		$600K Buy
34,025
+5,858
+21% +$109K ﹤0.01% 1018
2020
Q2 		$530K Buy
28,167
+8,858
+46% +$157K ﹤0.01% 1054
2020
Q1 		$334K Buy
19,309
+1,236
+7% +$25.8K ﹤0.01% 1104
2019
Q4 		$382K Buy
18,073
+1,866
+12% +$37.8K ﹤0.01% 1081
2019
Q3 		$317K Buy
16,207
+800
+5% +$14.7K ﹤0.01% 1073
2019
Q2 		$269K Sell
15,407
-2,648
-15% -$47.7K ﹤0.01% 1044
2019
Q1 		$334K Buy
18,055
+4,947
+38% +$88.2K ﹤0.01% 1031
2018
Q4 		$211K Buy
+13,108
New +$207K ﹤0.01% 1074

Other funds holding MPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Natixis Advisors's MPT Position: Q1 2026 in Review

Natixis Advisors reduced its Medical Properties Trust (MPT) stake by 38% in Q1 2026, selling an estimated $340K and leaving 106,516 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.

Natixis Advisors first reported a position in MPT in Q4 2018 and has held it in 27 quarters since. The position peaked at $2.79M in Q1 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Natixis Advisors held 106,516 shares of Medical Properties Trust worth $493K as of Q1 2026.
  • Natixis Advisors sold 65,243 Medical Properties Trust shares in Q1 2026, an estimated $340K.
  • Medical Properties Trust made up ﹤0.01% of Natixis Advisors's portfolio in Q1 2026, its #1557 holding.
  • Natixis Advisors first reported a position in Medical Properties Trust in Q4 2018 and has held it in 27 quarters since.
  • Natixis Advisors's Medical Properties Trust position peaked at $2.79M in Q1 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.